SCHEMBL4359436

SCHEMBL4359436

Oc1c(Cl)cc(Cl)cc1NCc1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
UTS2R Q9UKP6 1/20 0.43
HSD17B13 Q7Z5P4 2/20 0.43
KDM4E B2RXH2 2/20 0.42
CYP3A4 P08684 1/20 0.42
CD38 P28907 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
P2RX7 Q99572 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GFER P55789 1/20 0.40
EPHX2 P34913 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
ACP1 P24666 1/20 0.39
STK39 Q9UEW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355638 0.82 UTS2R (0.51) GAAUTS2RHSD17B13KDM4ECYP3A4
SCHEMBL4355466 0.81 CYP3A4 (0.44) GAAUTS2RHSD17B13KDM4ECYP3A4
SCHEMBL4353017 0.77 MEN1 (0.46) GAACD38MEN1KMT2AGFER
SCHEMBL4347512 0.76 KMT2A (0.62) GAAKDM4ECYP3A4KMT2AHPGD
SCHEMBL6691471 0.75 UTS2R (0.56) GAAUTS2RKDM4ECYP3A4CD38
SCHEMBL4353145 0.75 KDM4E (0.43) KDM4ECYP3A4CD38HDAC3HDAC1
SCHEMBL4347784 0.75 ITGB2 (0.44) GAAKDM4ECYP3A4MEN1KMT2A
SCHEMBL4348617 0.75 MEN1 (0.53) GAACYP3A4HDAC3HDAC1HDAC2
SCHEMBL4359272 0.74 GAA (0.42) GAAMEN1KMT2AGFERLMNA
SCHEMBL4355631 0.74 GAA (0.42) GAAKDM4ECYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 GAA 4010/4885UTS2R 1205/4885HSD17B13 143/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 GAA 3384/4885UTS2R 635/4885HSD17B13 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.